Personalis financials
$16.35+0.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $69.6M | $84.6M | $73.5M | $65.0M | $85.5M | $78.6M | $65.2M |
| Gross profit | $15.8M | $26.8M | $18.2M | $13.3M | $31.7M | $20.1M | $22.1M |
| Gross margin | 22.7% | 31.7% | 24.8% | 20.5% | 37.0% | 25.6% | 33.9% |
| Operating income | -$88.1M | -$68.3M | -$104.4M | -$115.5M | -$65.4M | -$42.1M | -$22.4M |
| Net income | -$81.3M | -$81.3M | -$108.3M | -$113.3M | -$65.2M | -$41.3M | -$25.1M |
| Net margin | −116.7% | −96.1% | −147.4% | −174.2% | −76.3% | −52.5% | −38.5% |
| Diluted EPS | $-0.91 | $-1.37 | $-2.25 | $-2.48 | $-1.49 | $-1.20 | $-1.39 |
| EBITDA | -$78.0M | -$57.3M | -$96.3M | -$107.1M | -$59.3M | -$36.4M | -$17.7M |
| Operating cash flow | -$74.9M | -$45.1M | -$56.3M | -$70.2M | -$70.8M | -$42.7M | -$18.1M |
| Free cash flow | -$79.5M | -$46.8M | -$67.2M | -$120.1M | -$81.9M | -$45.9M | -$26.5M |
| Diluted shares | 89.2M | 59.3M | 48.2M | 45.7M | 43.9M | 34.4M | 18.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $124.2M | $91.4M | $57.0M | $89.1M | $105.6M | $68.5M |
| Short-term investments | $115.7M | $93.6M | $57.2M | $78.5M | $181.5M | $134.8M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $334.2M | $270.3M | $225.1M | $292.7M | $396.5M | $244.8M |
| Total liabilities | $73.0M | $67.3M | $95.7M | $74.6M | $86.2M | $49.9M |
| Shareholders' equity | $261.2M | $203.0M | $129.4M | $218.1M | $310.3M | $194.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology